Diagnostic role of collagen-III and matrix metalloproteinase-1 for early detection of hepatocellular carcinoma

References

• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314.
   PubMed Web of Science ®Google Scholar
• Danila M, Sporea I. Ultrasound screening for hepatocellular carcinoma in patients with advanced liver fibrosis. An overview. Med Ultrason. 2014;16:139–144.
   PubMed Web of Science ®Google Scholar
• El-Serag HB. Hepatocellular carcinoma. New Engl J Med. 2011;365:1118–1127.
   PubMed Web of Science ®Google Scholar
• Rich NE, Yopp AC, Singal AG. Medical management of hepatocellular carcinoma. J Oncol Pract. 2017;13:356–364.
   PubMed Web of Science ®Google Scholar
• Tsuchiya N, Sawada Y, Endo I, et al. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2015;21:10573.
   PubMed Web of Science ®Google Scholar
• Aghoram R, Cai P, Dickinson JA. Alpha‐foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B. Cochrane Database Syst Rev. 2012;9:CD002799.
   Google Scholar
• Lou J, Zhang L, Lv S, et al. Biomarkers for hepatocellular carcinoma. Biomark Cancer. 2017;9:1–9.
   PubMedGoogle Scholar
• Sherman M. Current status of alpha-fetoprotein testing. Gastroenterol Hepatol. 2011;7:113–114.
   Google Scholar
• Giannini EG, Marenco S, Borgonovo G, et al. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Hepatol. 2012;56:1371–1379.
   PubMed Web of Science ®Google Scholar
• Gupta S, Bent S, Kohlwes J. Test characteristics of α-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C: a systematic review and critical analysis. Ann Intern Med. 2003;139:46–50.
   PubMed Web of Science ®Google Scholar
• Soresi M, Terranova A, Licata A, et al. Surveillance program for diagnosis of HCC in liver cirrhosis: role of ultrasound echo patterns. Biomed Res Int. 2017;2017:4932759.
   PubMedGoogle Scholar
• Walker C, Mojares E, Del Río Hernández A. Role of extracellular matrix in development and cancer progression. Int J Mol Sci. 2018;19:3028.
   PubMed Web of Science ®Google Scholar
• Di Lullo GA, Sweeney SM, Körkkö J, et al. Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem. 2002;277:4223–4231.
   PubMed Web of Science ®Google Scholar
• Alcolado R, Arthur M, Iredale J. Pathogenesis of liver fibrosis. Clin Sci. 1997;92:103–112.
   PubMed Web of Science ®Google Scholar
• Pererrone F, Daniele B, Gaeta GB, et al. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatol. 2000;31:840–845.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329–338.
   PubMed Web of Science ®Google Scholar
• Yang JD, Roberts LR. Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 2010;7:448–458.
   PubMed Web of Science ®Google Scholar
• Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997;349:825–832.
   PubMed Web of Science ®Google Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci. 1979;76:4350–4354.
   PubMed Web of Science ®Google Scholar
• Attallah AM, El-Far M, Ghaly MF, et al. Circulating levels of Collagen-III and MMP-1 in patients with chronic hepatitis C co-infected with hepatitis B virus. Br J Biomed Sci. 2017;74:95–100.
   PubMed Web of Science ®Google Scholar
• Attallah AM, El-Far M, Abdel Malak CA, et al. Fibro-check: a combination of direct and indirect markers for liver fibrosis staging in chronic hepatitis C patients. Ann Hepatol. 2015;14:225–233.
   PubMed Web of Science ®Google Scholar
• Sengupta S, Parikh ND. Biomarker development for hepatocellular carcinoma early detection: current and future perspectives. Hepatol Oncol. 2017;4:111–122.
   PubMed Web of Science ®Google Scholar
• Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23:5282.
   PubMed Web of Science ®Google Scholar
• Wang J, Jain S, Chen D, et al. Development and evaluation of novel statistical methods in urine biomarker-based hepatocellular carcinoma screening. Sci Rep. 2018;8:3799.
   PubMed Web of Science ®Google Scholar
• Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196:395–406.
   PubMed Web of Science ®Google Scholar
• Baiocchini A, Montaldo C, Conigliaro A, et al. Extracellular matrix molecular remodeling in human liver fibrosis evolution. PloS One. 2016;11:e0151736–e0151736.
   PubMed Web of Science ®Google Scholar
• Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterol. 2008;134:1655–1669.
   PubMed Web of Science ®Google Scholar
• Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199–210.
   PubMed Web of Science ®Google Scholar
• Schrader J, Gordon‐Walker TT, Aucott RL, et al. Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatol. 2011;53:1192–1205.
   PubMed Web of Science ®Google Scholar
• Hernandez–Gea V, Toffanin S, Friedman SL, et al. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterol. 2013;144:512–527.
   PubMed Web of Science ®Google Scholar
• Schraml C, Kaufmann S, Rempp H, et al. Imaging of HCC-current state of the art. Diagnostics. 2015;5:513–545.
   Web of Science ®Google Scholar
• Shang S, Plymoth A, Ge S, et al. Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology. 2012;55:483–490.
   PubMed Web of Science ®Google Scholar
• Zhu WW, Guo JJ, Guo L, et al. Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma. Clin Cancer Res. 2013;19:3944–3954.
   PubMed Web of Science ®Google Scholar
• Shen Q, Fan J, Yang XR, et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol. 2012;13:817–826.
   PubMed Web of Science ®Google Scholar